Search research articles
Contact Us
Filters
Showing results (81-90 of 212) with videos related to
Page
of 22
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
March 18, 2020
SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes
Qing Zhang, Mintallah Haider, Najla H Al Ali, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 15, 2017
A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia
Abu-Sayeef Mirza, Jeffrey E Lancet, Kendra Sweet, et al.
Cancer
|
March 1, 2014
Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromes
David P Steensma, Rami S Komrokji, Richard M Stone, et al.
American Journal of Hematology
|
December 23, 2016
Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience
Patrick T Griffin, Rami S Komrokji, Kendra Sweet, et al.
British Journal of Haematology
|
July 22, 2014
SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia
Anjali S Advani, Shannon McDonough, Edward Copelan, et al.
Leukemia Research
|
December 26, 2008
A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia
Jeffrey E Lancet, Maria R Baer, George E Duran, et al.
Leukemia Research
|
April 17, 2009
Outcome of patients with myelodysplastic syndromes in the Veterans Administration population
Rami S Komrokji, Gina M Matacia-Murphy, Najla H Al Ali, et al.
Leukemia Research
|
November 28, 2013
High rate of uncaptured myelodysplastic syndrome cases and an improved method of case ascertainment
Christopher R Cogle, Michelle R Iannacone, Daohai Yu, et al.
Scientific Reports
|
May 27, 2016
Improved intra-array and interarray normalization of peptide microarray phosphorylation for phosphorylome and kinome profiling by rational selection of relevant spots
Jetse Scholma, Gwenny M Fuhler, Jos Joore, et al.
Health and Quality of Life Outcomes
|
September 10, 2009
Valuation of transfusion-free living in MDS: results of health utility interviews with patients
Agota Szende, Caroline Schaefer, Thomas F Goss, et al.
Page
of 22
Search research articles
Search
Showing results (81-90 of 212) with videos related to
Sort By:
Page
of 22
Clinical Lymphoma, Myeloma & Leukemia
|
March 18, 2020
SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes
Qing Zhang, Mintallah Haider, Najla H Al Ali, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 15, 2017
A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia
Abu-Sayeef Mirza, Jeffrey E Lancet, Kendra Sweet, et al.
Cancer
|
March 1, 2014
Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromes
David P Steensma, Rami S Komrokji, Richard M Stone, et al.
American Journal of Hematology
|
December 23, 2016
Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience
Patrick T Griffin, Rami S Komrokji, Kendra Sweet, et al.
British Journal of Haematology
|
July 22, 2014
SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia
Anjali S Advani, Shannon McDonough, Edward Copelan, et al.
Leukemia Research
|
December 26, 2008
A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia
Jeffrey E Lancet, Maria R Baer, George E Duran, et al.
Leukemia Research
|
April 17, 2009
Outcome of patients with myelodysplastic syndromes in the Veterans Administration population
Rami S Komrokji, Gina M Matacia-Murphy, Najla H Al Ali, et al.
Leukemia Research
|
November 28, 2013
High rate of uncaptured myelodysplastic syndrome cases and an improved method of case ascertainment
Christopher R Cogle, Michelle R Iannacone, Daohai Yu, et al.
Scientific Reports
|
May 27, 2016
Improved intra-array and interarray normalization of peptide microarray phosphorylation for phosphorylome and kinome profiling by rational selection of relevant spots
Jetse Scholma, Gwenny M Fuhler, Jos Joore, et al.
Health and Quality of Life Outcomes
|
September 10, 2009
Valuation of transfusion-free living in MDS: results of health utility interviews with patients
Agota Szende, Caroline Schaefer, Thomas F Goss, et al.
Page
of 22